Learn about the new glaucoma medication which combines an alpha agonist and a beta-blocker in this medical report.
Read the full transcript »
Susan Sharma: This is insidermedicinein60 from California. A new glaucoma medication may improve compliance. The FDA has approved Combigan, which combines an alpha agonist and a beta-blocker. The medicine lowers IOP by 7 mmHg on average. It should not be used in those with asthma, COPD or heart block. From Wisconsin, a new study on over 1200 infants, who were followed for over a decade, shows that those who were breast fed for over 4 months had better improvement in lung function and volume. The beneficial effect, however, was not noted if the mother had asthma. In fact, those born to asthmatic mothers had a 6% reduction in lung function. From Minneapolis, general Mills is recalling over 4 million pizzas which are sold under the Totino's and Jeno's brand names. The recall was issued after health authorities noted that 9 out of 21 cases of E. Coli reported in the U.S. had resulted from ingesting one of these pizzas. And finally from London, a meta-analysis of 25 studies, which collectively enrolled over 3 million subjects, links pre-eclampsia to heart disease later in life. Women with pre-eclampsia had a 2 fold risk of heart disease, and were 4 times more likely to develop hypertension in later life. For Insidermedicine in 60, I'm Dr. Susan Sharma.
Copyright © 2005 - 2015 Healthline Networks, Inc. All rights reserved for Healthline.